Here's How Abbott Laboratories Increased Its Profits by 37% in Q1
Healthcare giant Abbott Laboratories (NYSE: ABT) reported quarterly earnings numbers last month, and the results were impressive with net earnings rising by 37% year over year. While investors may be tempted to dismiss the results as being largely due to strong COVID-19 testing volumes, the company's other businesses also generated positive growth.
What was really impressive was the company's ability to keep its costs under control and bank a significant chunk of that extra revenue as profit. Here's a closer look at what was behind the strong quarter.
Source Fool.com